Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

KYNTRA BIO, INC. (KYNB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

KYNTRA BIO, INC. (KYNB), most recent 12 months reported: revenue $4.62M, net income $183.19M, free cash flow -$38.06M. Latest balance sheet on file: liquid cash $91.32M. From SEC filings. Others in Pharmaceutical Preparations: HCW Biologics Inc. · RANI THERAPEUTICS HOLDINGS, INC. · Bolt Biotherapeutics, Inc. · ENTRADA THERAPEUTICS, INC. · Ensysce Biosciences, Inc. · CAMP4 Therapeutics Corporation · CHINA PHARMA HOLDINGS, INC. · ProPhase Labs, Inc.

Stock screener

Watchlist